Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05418296 · ClinicalTrials.gov registry record · NA

Assessing a Novel Virtual Environment That Assists With Activities of Daily Living

A NA study of Alzheimer Disease and Dementia, sponsored by mandy.

Completed
Registry status
NA
Development phase
38
Enrollment target
2
Study locations

NCT05418296 is a NA study of Alzheimer Disease and Dementia that has completed, run by mandy. The registered enrollment target is 38 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05418296, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by mandy.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target
2
Study locations

Study Summary

This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.

Interventions

  • DEVICE A novel digital health device

Study Locations (2)

California

  • Bruceville Point Senior Living Community - Elk Grove
  • Elder Ashram - Oakland

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2022-06-09
Est. Completion 2023-10-30
Phase NA

Sponsor

mandy

1 total trials

What the Registry Record Tells You About NCT05418296

The ClinicalTrials.gov registry entry for NCT05418296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is mandy, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which A novel digital health device is the first listed.

NCT05418296 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05418296 about?

NCT05418296 is a clinical study titled "Assessing a Novel Virtual Environment That Assists With Activities of Daily Living". This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.

What is the current status of trial NCT05418296?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-06-09. Estimated completion is 2023-10-30.

What conditions does trial NCT05418296 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Neurodegenerative Diseases.

What interventions are being tested in trial NCT05418296?

The interventions under investigation include: A novel digital health device (DEVICE).

Who is sponsoring clinical trial NCT05418296?

This trial is sponsored by mandy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05418296 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.